Elicera Therapeutics: Second complete response in CARMA study - Redeye
Bildkälla: Stockfoto

Elicera Therapeutics: Second complete response in CARMA study - Redeye

Redeye comments on the intriguing data from the phase I/II CARMA-study presented by Elicera this morning.

Redeye comments on the intriguing data from the phase I/II CARMA-study presented by Elicera this morning.
Börsvärldens nyhetsbrev